124 related articles for article (PubMed ID: 27416002)
41. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
[TBL] [Abstract][Full Text] [Related]
42. Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium.
Ahmadi N; Tsimikas S; Hajsadeghi F; Saeed A; Nabavi V; Bevinal MA; Kadakia J; Flores F; Ebrahimi R; Budoff MJ
Am J Cardiol; 2010 Feb; 105(4):459-66. PubMed ID: 20152239
[TBL] [Abstract][Full Text] [Related]
43. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.
Hörkkö S; Bird DA; Miller E; Itabe H; Leitinger N; Subbanagounder G; Berliner JA; Friedman P; Dennis EA; Curtiss LK; Palinski W; Witztum JL
J Clin Invest; 1999 Jan; 103(1):117-28. PubMed ID: 9884341
[TBL] [Abstract][Full Text] [Related]
44. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
[TBL] [Abstract][Full Text] [Related]
45. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease.
Fraley AE; Tsimikas S
Curr Opin Lipidol; 2006 Oct; 17(5):502-9. PubMed ID: 16960498
[TBL] [Abstract][Full Text] [Related]
46. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
[TBL] [Abstract][Full Text] [Related]
47. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
[TBL] [Abstract][Full Text] [Related]
48. Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosus.
Aho K; Vaarala O; Tenkanen L; Julkunen H; Jouhikainen T; Alfthan G; Palosuo T
Clin Exp Rheumatol; 1996; 14(5):499-506. PubMed ID: 8913651
[TBL] [Abstract][Full Text] [Related]
49. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
50. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity.
Tsimikas S; Witztum JL
Curr Opin Lipidol; 2008 Aug; 19(4):369-77. PubMed ID: 18607184
[TBL] [Abstract][Full Text] [Related]
51. Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a).
Ho JH; Adam S; Liu Y; Azmi S; Dhage S; Syed AA; Ammori BJ; Donn R; Heald A; Gibson MJ; Malik RA; Yang X; Durrington PN; Tsimikas S; Soran H
J Clin Lipidol; 2021; 15(2):320-331. PubMed ID: 33518459
[TBL] [Abstract][Full Text] [Related]
52. Novel monoclonal antibody recognizing triglyceride-rich oxidized LDLs associated with severe liver disease and small oxidized LDLs in normal subjects.
Sakurai T; Ichikawa A; Furukawa H; Wada N; Nagasaka A; Takahashi Y; Fujikawa M; Ikuta A; Furumaki H; Shiga M; Shimizu C; Hui SP; Jin S; Takeda S; Fuda H; Nagasaka H; Kobayashi S; Chiba H
Ann Clin Biochem; 2012 Sep; 49(Pt 5):456-62. PubMed ID: 22807504
[TBL] [Abstract][Full Text] [Related]
53. Pain Control by Targeting Oxidized Phospholipids: Functions, Mechanisms, Perspectives.
Oehler B; Brack A; Blum R; Rittner HL
Front Endocrinol (Lausanne); 2020; 11():613868. PubMed ID: 33569042
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma.
Nakajima T; Matsunaga T; Kawai S; Hokari S; Inoue I; Katayama S; Nagata A; Komoda T
Ann Clin Biochem; 2004 Jul; 41(Pt 4):309-15. PubMed ID: 15298743
[TBL] [Abstract][Full Text] [Related]
55. Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.
Braun S; Ndrepepa G; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A
Am Heart J; 2005 Sep; 150(3):550-6. PubMed ID: 16169339
[TBL] [Abstract][Full Text] [Related]
56. Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes.
Greco TP; Conti-Kelly AM; Anthony JR; Greco T; Doyle R; Boisen M; Kojima K; Matsuura E; Lopez LR
Am J Clin Pathol; 2010 May; 133(5):737-43. PubMed ID: 20395520
[TBL] [Abstract][Full Text] [Related]
57. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631
[TBL] [Abstract][Full Text] [Related]
58. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome.
Laczik R; Szodoray P; Veres K; Szomják E; Csípo I; Sipka S; Shoenfeld Y; Szekanecz Z; Soltész P
Lupus; 2011 Jun; 20(7):730-5. PubMed ID: 21505011
[TBL] [Abstract][Full Text] [Related]
59. Analysis of covalent modifications of proteins by oxidized phospholipids using a novel method of peptide enrichment.
Gao D; Willard B; Podrez EA
Anal Chem; 2014 Jan; 86(2):1254-62. PubMed ID: 24350680
[TBL] [Abstract][Full Text] [Related]
60. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.
Slot MC; Theunissen R; van Paassen P; Damoiseaux JG; Tervaert JW;
Clin Exp Immunol; 2007 Aug; 149(2):257-64. PubMed ID: 17521320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
